Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Pushes Discount Zocor; Health Plans Are Wary, But Pfizer Is Concerned

Executive Summary

The mixed response to Merck's efforts to reach rebate agreements with health plans to place brand Zocor on the lowest cost-sharing tiers of their formularies suggests it is unlikely such a strategy would be broadly adopted by brand firms going forward

You may also be interested in...



Crestor Discounting Keeps Allergan's Generic Off UnitedHealth Formulary

UnitedHealth will drop AstraZeneca's brand from coverage after competition drives down price of generic rosuvastatin.

Lifecycle Management Trends In China Show The Need To Get Ready For Fewer, Better Generics

In China, multinational pharmaceutical companies are not so worried about the patent cliff, as many off-patent products enjoy premium pricing and high-growth rates even when dozens of generics exist. But how long will the party last?

Can Watson Give Birth To A Pregnancy Franchise As It Helps Lay Lipitor To Rest?

Watson is progressing on a multi-year effort to diversify beyond its core U.S. generics business into branded drugs and international markets.

Related Content

UsernamePublicRestriction

Register

ID036688

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel